AHA GUIDELINES Bundle (free trial)

Hypertrophic Cardiomyopathy 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521559

Contents of this Issue

Navigation

Page 34 of 43

35 Section on obstructive HCM (See Figure 4) If patient decompensates while listed, evaluate for LVAD (2a) Evaluate for heart transplant (1) Section on symptomatic nonobstructive HCM Recurrent ventricular arrhythmias Cardiac myosin inhibitor should be discontinued if LVEF <50% and can be restarted at a lower dose if the LVEF recovers. CRT indicates cardiac resynchronization therapy; EF, ejection fraction; GDMT, guideline- directed management and therapy; HCM, hypertrophic cardiomyopathy; ICD, implantable cardioverter-defibrillator; LBBB, le bundle branch block; LVAD, le ventricular assist device; LVEF, le ventricular ejection fraction; and NYHA, New York Heart Association. Reevaluation after GDMT

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Hypertrophic Cardiomyopathy 2024